Measurement of CD155 in Egyptian Adult Patients of acute Myeloid Leukemia and its Relation to Clinical Outcome
Mona Atia Maghawry Atia;
Abstract
his study was conducted to measure the level of CD155 in newly diagnosed adult Egyptian acute myeloid leukemia patients and post chemotherapy, as well as its possible the correlation of CD155 with other prognostic factors in AML.
AML subjects had higher serum CD155 level compared to control subjects with statistically highly significant difference (P-value <0.001).
AML patients with high risk cytogenetics had higher serum CD155 level compared to those with non-high risk cytogenetics (P <0.001).
High levels of CD155 at diagnosis is associated with high rate of relapse with statistically highly significant difference (P <0.001).
AML subjects had higher serum CD155 level compared to control subjects with statistically highly significant difference (P-value <0.001).
AML patients with high risk cytogenetics had higher serum CD155 level compared to those with non-high risk cytogenetics (P <0.001).
High levels of CD155 at diagnosis is associated with high rate of relapse with statistically highly significant difference (P <0.001).
Other data
| Title | Measurement of CD155 in Egyptian Adult Patients of acute Myeloid Leukemia and its Relation to Clinical Outcome | Other Titles | قياس علامة 155 فى المرضى بسرطان الدم الحادة وعلاقته بالنتائج السريرية ونسب الشفاء | Authors | Mona Atia Maghawry Atia | Issue Date | 2019 |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| CC3759.pdf | 654.47 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.